H.A. Jinnah got his MD degree and a PhD degree in Neuroscience from the University of California in San Diego. He then completed a Neurology Residency at Johns Hopkins University in Baltimore, and was on the faculty there for 10 years. Since 2009 he has been at Emory University in Atlanta, where he is Professor of Neurology, Human Genetics, and Pediatrics. He has more than 300 publications, with a special interest in research relating to dystonia, neurogenetics, and the development of novel treatments.Bettina Balint is assistant professor for clinical research on complex movement disorders and Parkinson´s disease at the University of Zurich, and head of the movement disorder department at the University Hospital Zurich. Her clinical and academic career in neurology comprised specialist training in movement disorders and autoimmune diseases at the University Hospital Heidelberg, Germany, the UCL Queen Square Institute of Neurology, London, and the neuroimmunology department of the Universityof Oxford, UK. She has numerous publications including peer-reviewed journal articles, book chapters and books, serves on various guideline committees, task forces, editorial boards and regularly lecture at various national and international meetings.Victor Fung is Professor of Neurology and Motor Control, Sydney Medical School, The University of Sydney, and Director of the Movement Disorders Unit and past Head, Department of Neurology, Westmead Hospital in Sydney, Australia. He is President of the International Parkinson and Movement Disorder Society (MDS) and a past-President of the Movement Disorder Society of Australia and New Zealand. He has a clinical and research interest in Parkinson's disease and movement disorders with over 200 peer-reviewed publications and an h-index of 57.

• Chapter 1: A brief history of the concept of dystonia and its evolutionChapter 2: The defining clinical features of dystoniaChapter 3: Classification and diagnostic strategy for dystoniaChapter 4: Epidemiology of the dystoniasChapter 5: Cervical dystoniasChapter 6: Craniofacial dystoniasChapter 7: Laryngeal dystoniasChapter 8: Limb dystoniasChapter 9: Isolated generalized dystoniasChapter 10: Musician's and other task-specific dystoniasChapter 11: Non-motor features of dystoniaChapter 12: Dystonia and tremorChapter 13: Dystonia and parkinsonismChapter 14: Dystonia and ataxiaChapter 15: Dystonia and myoclonusChapter 16: Dystonia and cerebral palsyChapter 17: Dystonia and the paroxysmal dyskinesiasChapter 18: Dystonias combined with other featuresChapter 19: Dystonia induced by medications, illicit drugs, and environmental toxinsChapter 20: Dystonia and traumaChapter 21: Dystonia and autoimmunityChapter 22: Dystonia geneticsChapter 23: The neuroanatomical substrates of dystoniaChapter 24: Dystonia physiologyChapter 25: Psychogenic (functional) dystoniaChapter 26: Pseudodystonia and differential diagnosisChapter 27: Workup of dystoniaChapter 28: Symptom-targeted oral medications for dystoniaChapter 29: Special interventions for certain types of dystoniaChapter 30: Botulinum toxin treatment for dystoniaChapter 31: Surgical treatments for dystoniaChapter 32: Physiotherapy and complementary medicine for dystonia

H.A. Jinnah got his MD degree and a PhD degree in Neuroscience from the University of California in San Diego. He then completed a Neurology Residency at Johns Hopkins University in Baltimore, and was on the faculty there for 10 years. Since 2009 he has been at Emory University in Atlanta, where he is Professor of Neurology, Human Genetics, and Pediatrics. He has more than 300 publications, with a special interest in research relating to dystonia, neurogenetics, and the development of novel treatments.Bettina Balint is assistant professor for clinical research on complex movement disorders and Parkinson´s disease at the University of Zurich, and head of the movement disorder department at the University Hospital Zurich. Her clinical and academic career in neurology comprised specialist training in movement disorders and autoimmune diseases at the University Hospital Heidelberg, Germany, the UCL Queen Square Institute of Neurology, London, and the neuroimmunology department of the Universityof Oxford, UK. She has numerous publications including peer-reviewed journal articles, book chapters and books, serves on various guideline committees, task forces, editorial boards and regularly lecture at various national and international meetings.Victor Fung is Professor of Neurology and Motor Control, Sydney Medical School, The University of Sydney, and Director of the Movement Disorders Unit and past Head, Department of Neurology, Westmead Hospital in Sydney, Australia. He is President of the International Parkinson and Movement Disorder Society (MDS) and a past-President of the Movement Disorder Society of Australia and New Zealand. He has a clinical and research interest in Parkinson's disease and movement disorders with over 200 peer-reviewed publications and an h-index of 57.

• Chapter 1: A brief history of the concept of dystonia and its evolutionChapter 2: The defining clinical features of dystoniaChapter 3: Classification and diagnostic strategy for dystoniaChapter 4: Epidemiology of the dystoniasChapter 5: Cervical dystoniasChapter 6: Craniofacial dystoniasChapter 7: Laryngeal dystoniasChapter 8: Limb dystoniasChapter 9: Isolated generalized dystoniasChapter 10: Musician's and other task-specific dystoniasChapter 11: Non-motor features of dystoniaChapter 12: Dystonia and tremorChapter 13: Dystonia and parkinsonismChapter 14: Dystonia and ataxiaChapter 15: Dystonia and myoclonusChapter 16: Dystonia and cerebral palsyChapter 17: Dystonia and the paroxysmal dyskinesiasChapter 18: Dystonias combined with other featuresChapter 19: Dystonia induced by medications, illicit drugs, and environmental toxinsChapter 20: Dystonia and traumaChapter 21: Dystonia and autoimmunityChapter 22: Dystonia geneticsChapter 23: The neuroanatomical substrates of dystoniaChapter 24: Dystonia physiologyChapter 25: Psychogenic (functional) dystoniaChapter 26: Pseudodystonia and differential diagnosisChapter 27: Workup of dystoniaChapter 28: Symptom-targeted oral medications for dystoniaChapter 29: Special interventions for certain types of dystoniaChapter 30: Botulinum toxin treatment for dystoniaChapter 31: Surgical treatments for dystoniaChapter 32: Physiotherapy and complementary medicine for dystonia